Patient Guide: Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 12 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06941870
Status: 🟢 Enrolling Now
Condition: Factor VIII Deficiency
Phase: PHASE4

Where You Can Participate

This study is available at 12 locations across the country.

Top locations include:
  • • Los Angeles, California
  • • Indianapolis, Indiana
  • • Columbus, Ohio
  • • And 9 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy - Join Clinical Trial NCTNCT06941870

How to Join This Clinical Trial - NCTNCT06941870

Learn how to participate in this PHASE4 trial studying an investigational therapy for Factor VIII Deficiency. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Factor VIII Deficiency. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Factor VIII Deficiency
Treatment Being Tested
Investigational treatment
Study Phase
PHASE4 - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06941870 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 12 locations. Find a study site near you:

Clinical Research Site

Los Angeles, California 90007 - United States

Status: RECRUITING

Clinical Research Site

Indianapolis, Indiana 46260 - United States

Status: RECRUITING

Clinical Research Site

Columbus, Ohio 43203-1779 - United States

Status: RECRUITING

Clinical Research Site

Hamilton, Ontario L8N 3Z5 - Canada

Status: RECRUITING

Clinical Research Site

Hamilton, Ontario L8N 3Z5 - Canada

Status: RECRUITING

Clinical Research Site

Kawasaki, Kanagawa 216-8511 - Japan

Status: RECRUITING

Clinical Research Site

Hiroshima, 734-8551 - Japan

Status: RECRUITING

Clinical Research Site

Saitama, 330-8777 - Japan

Status: RECRUITING

Clinical Research Site

Tokyo, 160-0023 - Japan

Status: RECRUITING

Clinical Research Site

Kaohsiung City, 80756 - Taiwan

Status: RECRUITING

And 2 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE4 clinical trial for Factor VIII Deficiency:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships